A001360 Share Price Performance
₩1,577.00
-188.00 (-10.65%)
Price ₩1,577.00
Share Price₩1,577.00
SAMSUNG PHARM. Co., LTD. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A001360 Community Narratives
There are no narratives available yet.
Recent A001360 News & Updates
SAMSUNG PHARM. Co., LTD. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 135.06
- Gross Margin
- 100.00%
- Net Profit Margin
- 28.70%
- Debt/Equity Ratio
- 0%
SAMSUNG PHARM. Co., LTD. Competitors
Snowflake Analysis
About A001360
- Founded
- 1929
- Employees
- n/a
- CEO
- WebsiteView website
SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medicines, nutritional supplements, health tonics, antophlegm agents, and others, as well as quasi-medicines, vitamins and energy drinks, and functional foods. The company was founded in 1929 and is headquartered in Hwaseong-si, South Korea.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
South Korean Market Performance
- 7 Days: -0.006%
- 3 Months: 11.7%
- 1 Year: 32.9%
- Year to Date: 44.6%
The market has stayed flat over the 7 days. More promisingly, the market is up 33% over the past year. Looking forward, earnings are forecast to grow by 24% annually. Market details ›